PRIME Summit 2
From screening to protection: Advancing cardiorenal metabolic care with SGLT2 inhibitors

27-28 July 2024 | Grand Intercontinental Parnas, Seoul, South Korea

Merlin Thomas

Endocrinologist
Monash University
Australia

Javed Butler

Cardiologist
Baylor Scott and White Research Institute
United States

Jeong Hyun Park

Endocrinologist
Inje University Busan Paik Hospital
Korea

Mi-kyung Kim

Endocrinologist
Haeundae Paik Hospital, Inje University
Korea

Timestamp	Topic	Speaker
00:00-11:29	Introduction	Co-Chairs: Jeong Hyun Park
11:34-27:12	The ties that bind	Javed Butler
27:31-00:47:52	Case discussion: Unveiling hidden risks. who, when, and how to screen for T2D, HF, and CKD ~ Hypertension with or without dyslipidemia	Case presenter: Merlin Thomas Moderator: Jeong Hyun Park Panelists: Mi-Kyung Kim Merlin Thomas Javed Butler
00:47:52-01:02:47	Managing the double trouble: Evidence and recommendations of SGLT2 inhibitors in diabetes-related chronic kidney disease	Merlin Thomas
01:02:54-01:16:45	Live Q & A	Moderator: Merlin Thomas Panelists: Jeong Hyun Park Mi-Kyung Kim Javed Butler
01:17:11-01:31:02	Case discussion: Diabetic kidney disease screening and management in early type 2 diabetes ~ Early T2D patient	Case presenter: Merlin Thomas
01:31:02-01:44:33	Optimal glycemic control in type 2 diabetes: The role of early initiation of SGLT2 inhibitor and DPP4 inhibitor combination therapy	Mi-Kyung Kim
01:44:47-02:05:25	Live Q & A	Moderator: Merlin Thomas Panelists: Jeong Hyun Park Mi-Kyung Kim Javed Butler

Elevate your expertise
at PRIME.